A study in patients with rotator cuff tear to compare shoulder pain and function after platelet rich plasma injection with or without a shoulder nerve block.

Analgesic efficacy of suprascapular nerve block as an adjunct to platelet rich plasma in patients of rotator cuff tear - NIL

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/114128

Enrollment

Registered

2026-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: PRP plus nerve block. : Patients will receive ultrasound-guided PRP injection, 5 8 mL, at the area of rotator cuff tear/tendinosis. This will be followed by ultrasound-guided suprascapu

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 to 65 years with diagnosed rotator cuff tear, chronic shoulder pain for at least 3 months, and VAS score 4 or more will be included.

Exclusion criteria

Exclusion criteria: Patients with red flag signs, uncontrolled diabetes mellitus, severe cardiopulmonary disease, platelet count less than 100000 per microlitre or platelet dysfunction, pregnancy or lactation, or allergy to local anaesthetic agents will be excluded.

Design outcomes

Primary

Measure	Time frame
To compare the Constant-Murley Score between patients receiving platelet-rich plasma injection alone and patients receiving platelet-rich plasma injection with suprascapular nerve block.Timepoint: Baseline, immediate post-procedure, 1 week, 1 month, and 3 months after the procedure.	—

Secondary

Measure	Time frame
To compare pain scores, shoulder range of motion, analgesic requirement, patient satisfaction, clinical shoulder tests, platelet and leucocyte counts before and after PRP preparation, and adverse events between the two groups.Timepoint: Baseline, immediate post-procedure where applicable, 1 week, 1 month, and 3 months after the procedure. Analgesic requirement will be assessed during the first 72 hours and follow-up visits.	—

Measure

Time frame

To compare pain scores, shoulder range of motion, analgesic requirement, patient satisfaction, clinical shoulder tests, platelet and leucocyte counts before and after PRP preparation, and adverse events between the two groups.Timepoint: Baseline, immediate post-procedure where applicable, 1 week, 1 month, and 3 months after the procedure. Analgesic requirement will be assessed during the first 72 hours and follow-up visits.

—

Countries

India

Contacts

Public ContactPranvit Kour

Government Medical College and Hospital Chandigarh

vanitaanupam@gmail.com9646121649

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026